Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2009-12-31
2010-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The hypotheses for this trial are:
* Lens cleanliness measures between solutions will be no different.
* Subjective ratings between solutions will be no different.
* Ocular response between solutions will be no different.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Enfilcon A Soft Contact Lens When Compared to Galyfilcon A Soft Contact Lens
NCT01706770
Comparison of Two Multifocal Contact Lenses Worn on a Daily Disposable Basis
NCT01254760
Clinical Comparison of Two Daily Disposable Toric Lenses
NCT01362894
Bilateral Dispensing Clinical Trial of Stenfilcon A Against Etafilcon A for Astigmatism
NCT02410824
A Clinical Comparison of Two Daily Disposable Soft Contact Lenses
NCT04005885
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Easy Rub MPS
Complete Easy Rub Formula MPS
Complete Easy Rub Formula MPS
Multi-purpose solution
Aquify MPS
Aquify MPS
Multi-purpose solution
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Complete Easy Rub Formula MPS
Multi-purpose solution
Aquify MPS
Multi-purpose solution
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be at least 18 years old, male or female;
* Willing to comply with the wearing and clinical trial visit schedule as directed by the investigator;
* Have ocular health findings considered to be "normal" and which would not prevent the participant from safely wearing contact lenses;
* Is correctable to at least 6/12 (20/40) or better in each eye with contact lenses;
* Able to successfully wear one of the lens types to be used in this study on a daily wear (DW) basis in conjunction with any multi-purpose contact lens care solution (not including hydrogen peroxide-based systems) for at least one month prior to allocation of test or control solution;
Exclusion Criteria
* Any systemic disease that adversely affects ocular health e.g. diabetes, Graves disease, and auto-immune diseases such as ankylosing spondylitis, multiple sclerosis, Sjögrens syndrome and systemic lupus erythematosus. Conditions such as systemic hypertension and arthritis do not automatically exclude prospective participants;
* Use of, or a need for, concurrent category S3 and above ocular medication at enrolment and/or during the study;
* Use of, or a need for, any systemic medication or topical medications which may alter normal ocular findings/are known to affect a participant's ocular health/physiology or contact lens performance either in an adverse manner or beneficial manner at enrolment and/or during the study
18 Years
99 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott Medical Optics
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
COMP-319-9424
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.